Use of pre-, pro- and synbiotics in patients with acute pancreatitis: A meta-analysis

Table 4 Surgical outcomes stratified by severity of pancreatitis in this meta-analysis

	No. of studies	Synbiotic	Control	OR (95% CI)	P for effect size	P for heterogeneity
Septic morbidity	3	57/200	58/188	0.89 (0.57, 1.37)	0.58	0.16
Pancreatic infections	2	25/185	22/173	1.06 (0.58, 1.96)	0.84	0.07
Surgical intervention	2	32/185	21/173	1.07 (0.23, 4.92)	0.94	0.04
MOF and SIRS	3	43/200	36/188	0.65 (0.09, 4.44)	0.66	0.0005
Mortality	4	33/214	25/201	0.77 (0.22, 2.72)	0.69	0.02

OR: Odds ratio; CI: Confidence interval; MOF: Multi-organ failure; SIRS: Systemic inflammatory response syndrome.